News from delmar pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 20, 2015, 13:00 ET

DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM)

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing...

Apr 20, 2015, 08:00 ET

DelMar Pharmaceuticals Presents Updated Clinical Data on Phase I/II Study of VAL-083 in Refractory Glioblastoma Multiforme (GBM)

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing...

Apr 19, 2015, 13:00 ET

DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 for Treatment of Non-Small Cell Lung Cancer at the American Association of Cancer Research Annual Meeting

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing proven...

Apr 16, 2015, 08:05 ET

DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing...

Apr 07, 2015, 08:00 ET

DelMar Pharmaceuticals Announces Panel Participation in Cancer Advance Boston Conference on April 14, 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing...

Apr 01, 2015, 08:05 ET

DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it has appointed biopharmaceutical industry veteran,...

Mar 03, 2015, 08:00 ET

DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing...

Mar 02, 2015, 11:17 ET

DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a company focused on developing and commercializing proven cancer...

Feb 24, 2015, 08:00 ET

DelMar Pharmaceuticals to Present Clinical and Preclinical Abstracts for VAL-083 at the American Association of Cancer Research (AACR) Annual Meeting in April 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it will be presenting three abstracts based on...

Feb 12, 2015, 08:00 ET

DelMar Pharmaceuticals Announces December 31, 2014 Financial Results and Provides Corporate Update

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company") today announced the filing of its financial statements for the six...

Feb 11, 2015, 08:13 ET

DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, to the Board of Directors

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it has appointed Lynda Cranston, BScN, MScN,...

Feb 10, 2015, 09:35 ET

DelMar Pharmaceuticals Completes Offer to Exchange Common Stock for Outstanding Warrants

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), today announced that it has completed...

Jan 13, 2015, 08:00 ET

DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar", "the Company") today announced that the U.S. Patent and Trademark Office (USPTO) has issued a...

Jan 12, 2015, 08:00 ET

DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar", "the Company) provided an update on the Company's ongoing Phase I/II clinical trial with...

Jan 08, 2015, 08:00 ET

DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for Outstanding Warrants

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company", "we" or "our") today announced that it has commenced an offer to...

Jan 07, 2015, 08:00 ET

DelMar Pharmaceuticals to Present at Biotech Showcase™ 2015

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar", the "Company") announced today that Jeffrey Bacha, DelMar's president & CEO, will be...

Dec 02, 2014, 08:00 ET

DelMar Pharmaceuticals Joins OTCQX

 DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and "DelMar Pharma"), a clinical stage drug development company focused on the...

Nov 17, 2014, 08:00 ET
DelMar Pharmacokinetic Summary

DelMar Pharmaceuticals' Promising New Data Support the Potential of VAL-083 to Meet Significant Unmet Medical Needs in the Treatment of Glioblastoma Multiforme

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of new data supporting the...

Nov 14, 2014, 11:45 ET

DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 as a Potential New Treatment in Glioblastoma at the Society of Neuro-Oncology Annual Meeting

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of an abstract entitled, In vivo...

Nov 10, 2014, 08:00 ET

DelMar Pharmaceuticals Announces September 30, 2014 Results and Provides Corporate Update

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") today announced the filing of September 30, 2014 quarterly financial...